However, we cannot rule out the possibility that STZ-treatment may have had other, unanticipated and currently unknown effects, either independent of hyperglycemia or on other organ systems, that affected the survival of HFC diet fed SR-B1-KO/hypoE mice. This evidence concerns the gene SCARB1 and Hyperglycemia.